Modulators of Chromosome 9 Open Reading Frame 72 Gene Expression and Uses Thereof
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- SANGAMO THERAPEUTICS, INC., Brisbane, California has been assigned a patent (No. US 12139517 B2, initially filed April 23, 2020) developed by three inventors Joseph F. Nabhan, Arlington, Massachusetts; Amrutha Pattamatta, Watertown, Massachusetts; and Mohammad Samie, Richmond, California, for "Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof." . . .